Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Abivax develops medicines that alter the body's natural immune system mechanisms.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Primmune Therapeutics is a Biotechnology company.
Powering precision proteomics to enable to the earliest detection of disease.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 15 different industry categories.
Among tracked funding rounds, Candid Therapeutics received $505.0M in a Undisclosed round. Samsara BioCapital's total known invested capital is $14.2B.
Samsara BioCapital's average investment size is $107.7M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include Claris Biotherapeutics, Jasper Therapeutics, Neurogene, Nura Bio, Memento Medicines. These companies were founded in 2020 or later.